Phelan McDermid Syndrome: From Genetic Discoveries to Animal Models and Treatment

Journal of Child Neurology
Hala Harony-NicolasJoseph D Buxbaum

Abstract

Phelan-McDermid syndrome or 22q13.3 deletion syndrome is a rare neurodevelopmental disorder characterized by generalized developmental delay, intellectual disability, absent or delayed speech, seizures, autism spectrum disorder, neonatal hypotonia, physical dysmorphic features, and recurrent medical comorbidities. Individuals with Phelan-McDermid syndrome have terminal deletions of the chromosomal region 22q13.3 encompassing SHANK3, a gene encoding a structural component of excitatory synapses indispensable for proper synaptogenesis and neuronal physiology, or point mutations within the gene. Here, we review the clinical aspects of the syndrome and the genetic findings shedding light onto the underlying etiology. We also provide an overview on the evidence from genetic studies and mouse models that supports SHANK3 haploinsufficiency as a major contributor of the neurobehavioral manifestations of Phelan-McDermid syndrome. Finally, we discuss how all these discoveries are uncovering the pathophysiology of Phelan-McDermid syndrome and are being translated into clinical trials for novel therapeutics ameliorating the core symptoms of the disorder.

Associated Clinical Trials

References

Jun 22, 1999·The Journal of Biological Chemistry·H ZitzerH J Kreienkamp
Oct 21, 1999·Biochemical and Biophysical Research Communications·T M BoeckersE D Gundelfinger
Jun 30, 2001·American Journal of Human Genetics·M C BonagliaO Zuffardi
Jun 29, 2004·Trends in Neurosciences·Mark F BearStephen T Warren
Apr 9, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Gautier RoussignolLaurent Fagni
May 6, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Carlo SalaLaurent Fagni
Aug 2, 2005·American Journal of Medical Genetics. Part a·Aaron R JeffriesJohn Powell
Nov 15, 2005·Journal of Medical Genetics·M C BonagliaO Zuffardi
Jun 24, 2006·Trends in Biochemical Sciences·Eckart D GundelfingerJames U Bowie
Mar 17, 2007·Science·Jonathan SebatMichael Wigler
Apr 11, 2007·Journal of Neurochemistry·Silvana BeriRoberto Giorda
Nov 14, 2007·American Journal of Human Genetics·Rainald MoessnerStephen W Scherer
Jan 19, 2008·The Journal of Physiology·Gül Dölen, Mark F Bear
Feb 7, 2008·American Journal of Human Genetics·Christian R MarshallStephen W Scherer
Feb 15, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Albert Y HungMorgan Sheng
May 21, 2008·Handbook of Experimental Pharmacology·H-J Kreienkamp
Jun 5, 2008·European Journal of Human Genetics : EJHG·Heather L WilsonHeather E McDermid
Jul 11, 2008·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Julie GauthierGuy A Rouleau
Oct 16, 2008·European Journal of Human Genetics : EJHG·Maria Clara BonagliaOrsetta Zuffardi
Feb 5, 2009·Developmental Medicine and Child Neurology·Jennifer Krebs SeidaBrenda Clark
Feb 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·Daniela TropeaMriganka Sur
Aug 8, 2009·Nature Medicine·Dan Ehninger, Alcino J Silva
Feb 27, 2010·American Journal of Medical Genetics. Part a·S U DharT Sahoo
Mar 23, 2010·Pharmacology & Therapeutics·Gül DölenMark F Bear
Apr 14, 2010·Proceedings of the National Academy of Sciences of the United States of America·Julie GauthierUNKNOWN S2D Team
Jul 9, 2010·Nature·Alika K MaunakeaJoseph F Costello
Sep 3, 2010·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Jill A RosenfeldLisa G Shaffer
Nov 26, 2010·Annual Review of Medicine·Dilja D Krueger, Mark F Bear
Jan 11, 2011·The EMBO Journal·Andreas M GrabruckerTobias M Boeckers

❮ Previous
Next ❯

Citations

Oct 5, 2016·Pediatric Neurology·Clara D M van KarnebeekElizabeth Berry-Kravis
Aug 6, 2016·Autism Research : Official Journal of the International Society for Autism Research·Thomas C JaramilloCraig M Powell
Aug 28, 2016·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Fatima Yousif IsmailMichael V Johnston
Feb 13, 2018·Continuum : Lifelong Learning in Neurology·Clara D M van Karnebeek
Dec 7, 2017·American Journal of Medical Genetics. Part a·Kent D McKelveyJeffrey Clothier
Jan 24, 2018·European Journal of Human Genetics : EJHG·Andrew R MitzAudrey Thurm
Nov 6, 2018·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Amanda R RendallR Holly Fitch
Feb 9, 2020·Cells·Anke HoffmannDietmar Spengler
Jul 5, 2018·Frontiers in Synaptic Neuroscience·Keerthi Thirtamara RajamaniHala Harony-Nicolas
Mar 7, 2019·Frontiers in Cellular Neuroscience·Milen Velinov
Jun 7, 2017·Acta Neuropathologica·Merina VarghesePatrick R Hof
Aug 25, 2018·Stem Cell Research & Therapy·Aline Vitrac, Isabelle Cloëz-Tayarani
Oct 21, 2017·Autism Research : Official Journal of the International Society for Autism Research·Crystal T EngineerMichael P Kilgard
Jun 18, 2020·Orphanet Journal of Rare Diseases·Kimberly GoodspeedDiane Linnehan
Dec 10, 2017·Current Opinion in Neurobiology·Carla Em GoldenSilvia De Rubeis
Jul 22, 2020·Current Opinion in Genetics & Development·Tomomi Aida, Guoping Feng
Jul 31, 2021·Pediatric Neurology·Yitzchak Frank
Jul 28, 2021·Autism Research : Official Journal of the International Society for Autism Research·Carla E M GoldenJoseph D Buxbaum
Sep 10, 2021·Molecular Psychiatry·Simone ChiolaAleksandr Shcheglovitov

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain developing: Influences & Outcomes

This feed focuses on influences that affect the developing brain including genetics, fetal development, prenatal care, and gene-environment interactions. Here is the latest research in this field.

Autism: Treatment Targets

The absence of effective treatments for autism are due to the high clinical and genetic heterogeneity between affected individuals, restricted knowledge of the underlying pathophysiological mechanisms, and the lack of reliable diagnostic biomarkers. Identification of more homogenous biological subgroups is therefore essential for the development of novel treatments based on the molecular mechanisms underpinning autism and autism spectrum disorders. Find the latest research on autism treatment targets here.

Autism

Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research on autism.